Healthcare
Asahi Intecc Co., Ltd.(AHICF)
Live Price
Offline$21.41
+0.00% today
Window Change
+0.00%
Window
May 29, 2026 โ Jun 23, 2026
- Market Cap
- $861.24B
- Revenue Growth
- +11.6%
- EPS Growth
- -19.4%
- Dividend Yield
- 0.7%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 17 bars ยท May 29, 2026 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Asahi Intecc Co., Ltd. (AHICF) is a Healthcare stock with a market cap of $861.24B and listed on OTC. The stock last traded around $21.41 and up 0.0% across the available one-year price window (May 29, 2026 โ Jun 23, 2026). Baseline metrics include revenue growth of +11.6%, EPS growth of -19.4%, a dividend yield of 0.7%. What stands out right now is revenue +11.6%, EPS -19.4%, free cash flow +32.3% with operating margin 28.5% and ROIC 14.1%. The dividend is present but secondary, with a yield around 0.7%. Valuation already assumes a fairly strong business story at P/E 48.7 and price/sales 6.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines AHICF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+11.6% vs +7.6% peer median
Operating Margin
Above sector median
+28.5% vs +19.4% peer median
P/E
Above sector median
48.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
2026 was reported on May 15, 2026 with an EPS surprise of +137.2% and a revenue surprise of +4.0%.
The operating picture looks softer than before
Revenue is at +11.6% and EPS is at -19.4%, with operating margin around 28.5%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 13, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Benchmark Edge
AHICF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
AHICF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
AHICF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for AHICF and SPY.
Company Overview
Asahi Intecc Co., Ltd.
Other OTC
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, China, and internationally. It operates through two segments: the Medical Division and the Device Division. The company provides percutaneous transluminal coronary angioplasty (PTCA) guide wires, PTCA guiding catheters, PTCA balloon catheters, and penetration catheters for cardiology; peripheral guide wires, IVR guide wires, micro catheters, and gastrointestinal and cerebrovascular system guide wires for peripheral vascular, abdominal vascular, and cerebrovascular systems; and guide wires and catheters for angiography. It also offers OEM/ODM services for medical devices; and medical and industrial components, such as element wires, stranded conductors, coils, tubes, terminal processing products, and other products, as well as develops, manufactures, and sells ultra-fine stainless steel wire ropes, terminal processed products, etc. The company was formerly known as Asahi Mini Rope Sales Co., Ltd. and changed its name to Asahi Intecc Co., Ltd. in July 1988. Asahi Intecc Co., Ltd. was incorporated in 1976 and is headquartered in Aichi, Japan.
- Leadership
- Kenji Miyata
- IPO Date
- May 28, 2013
- Employees
- 9.4k
- Street Address
- 3-100 Akatsuki-cho
- Mailing
- Aichi, 489-0071
- Region
- Aichi, JP
- Reporting Currency
- USD
- Investor Line
- 81 5 6148 5551
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 48.7
- EV/EBITDA
- 17.6
- Price/Sales
- 6.6
- Price/Book
- 5.5
Growth
- Revenue
- +11.6%
- EPS
- -19.4%
- Free Cash Flow
- +32.3%
Profitability
- Gross Margin
- 69.3%
- Operating Margin
- 28.5%
- Net Margin
- 13.6%
- ROE
- 11.6%
- ROIC
- 14.1%
Balance Sheet
- Debt/Equity
- 0.05
- Current Ratio
- 4.68
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.